ZNF304 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 5.05329111888386E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.43389999999843E-05 |
Normal-vs-Stage2 |
5.34989999967372E-07 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
4.776500E-03 |
Stage1-vs-Stage2 |
1.436810E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
5.527200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
7.161200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.90590029606142E-10 |
Normal-vs-AfricanAmerican |
7.699900E-02 |
Normal-vs-Asian |
1.678400E-02 |
Caucasian-vs-AfricanAmerican |
3.872200E-02 |
Caucasian-vs-Asian |
4.247000E-01 |
AfricanAmerican-vs-Asian |
8.914100E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.229490E-04 |
Normal-vs-Female |
5.99310001625497E-09 |
Male-vs-Female |
3.172400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
7.583600E-04 |
Normal-vs-Extreme_Weight |
1.57903999999931E-05 |
Normal-vs-Obese |
2.218000E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
9.967000E-01 |
Normal_Weight-vs-Obese |
1.388420E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
8.468200E-02 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.903610E-01 |
Normal-vs-Age(41-60Yrs) |
5.083400E-03 |
Normal-vs-Age(61-80Yrs) |
1.17710285962858E-11 |
Normal-vs-Age(81-100Yrs) |
2.429400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.243400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.816460E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.402000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.750600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.752600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.815800E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
7.133000E-01 |
Normal-vs-Grade 3 |
7.095000E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
8.037000E-01 |
Grade 2-vs-Grade 4 |
7.133000E-01 |
Grade 3-vs-Grade 4 |
7.095000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.70870000371082E-08 |
Normal-vs-N1 |
5.842400E-03 |
N0-vs-N1 |
2.008600E-01 |
|
|